Conclusions
Certain parameters/drug classes well worked out
Still issues with variability (with ADME parameters, MICs, local effects, etc.)
Multiple meetings held where, at this time, PK/PD is seen as strong supportive evidence but that for reasons listed, should not be used in lieu of clinical evidence